DYRK1A Inhibitors as Potential Therapeutics for β-Cell Regeneration for Diabetes.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of medicinal chemistry"
DOI: 10.1021/acs.jmedchem.0c02050
Abstract: According to the World Health Organization (WHO), 422 million people are suffering from diabetes worldwide. Current diabetes therapies are focused on optimizing blood glucose control to prevent long-term diabetes complications. Unfortunately, current therapies have failed… read more here.
Keywords: therapeutics cell; cell proliferation; potential therapeutics; regeneration ... See more keywords